Target intelligence / Profile preview

Ribosomal protein S29 pseudogene 11 (RPS29P11)

Target: RPS29P11
Molecular classification: Pseudogene

Overview

Ribosomal protein S29 pseudogene 11 (RPS29P11) is a processed pseudogene derived from the ribosomal protein S29 gene family. It is annotated as a noncoding pseudogene, does not produce a protein, and has no established molecular function, disease association, or clinical relevance. Unlike the functional ribosomal protein S29, which is a component of the small ribosomal 40S subunit and implicated in disorders such as Diamond-Blackfan anemia, RPS29P11 is not a therapeutic target and should not be considered for drug development or biological studies focused on protein function or regulation[4][6].

Other names: RPS29P11ribosomal protein S29 pseudogene 11

Beyond the preview

Go deeper on Ribosomal protein S29 pseudogene 11 (RPS29P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S29 pseudogene 11 (RPS29P11).

Explore the full profile